potential indications for glp-1 receptor agonists keep expanding Drugs: Where We Are and Where We're Going — Summit Re GLP-1 Receptor Agonists as Treatments

Tirzepatide is a new drug that has shown promising results in clinical trials for weight loss

Amgen & Viking Therapeutics 8% Given that our portfolio is built for the next 5 years, it makes sense to allocate a small portion to possible new entrants

Mechanism of Action : Levocarnitine belongs to the class of medications called amino acid derivatives

Nevertheless, since GSH cannot be administered directlybecause of its insufficient absorption, stability and solubilityanalogues have been obtained, through modifications at the -glutamyl, cysteine and glycine moieties, and/or the functionalisation of the central cysteine, that are able to inhibit the activity of GSTs 69,87,105

In your 20s and 30s, sports injuries or accidental trauma can severely impact your performance and recovery time

As the population of diabetic patients is continuously expanding around the world, the demand for effective glucose-lowering treatments is magnifying significantly